Custom - fit minimally invasive total knee arthroplasty : effect on <font color="blue">blood_1</font> <font color="blue">loss_1</font> <font color="blue">and_1</font> <font color="blue">early_1</font> <font color="blue">clinical_1</font> <font color="blue">outcomes_1</font> <font color="blue">._1</font> 
<br>
<br> PURPOSE Recently , new custom - fit pin guides in total knee arthroplasty ( TKA ) have been introduced . Use of these guides may <font color="blue">reduce_1</font> <font color="blue">operating_1</font> <font color="blue">time_1</font> <font color="blue">._1</font> Use of the guides combined with the absence of intramedullary alignment jigs may lead to <font color="blue">reduced_1</font> <font color="blue">blood_1</font> <font color="blue">loss_1</font> <font color="blue">and_1</font> <font color="blue">improved_1</font> <font color="blue">early_1</font> <font color="blue">outcomes_1</font> <font color="blue">._1</font> Our aim was to <font color="blue">evaluate_1</font> <font color="blue">blood_1</font> <font color="blue">loss_1</font> <font color="blue">and_1</font> <font color="blue">early_1</font> <font color="blue">clinical_1</font> <font color="blue">outcomes_1</font> in patients undergoing minimally invasive TKA using <font color="blue">custom_1</font> <font color="blue">-_1</font> <font color="blue">fit_1</font> <font color="blue">magnetic_1</font> <font color="blue">resonance_1</font> <font color="blue">imaging_1</font> <font color="blue">(_1</font> <font color="blue">MRI)-based_1</font> <font color="blue">pin_1</font> <font color="blue">guides_1</font> <font color="blue">._1</font> 
<br> METHODS A prospective study in 80 patients was carried out . Patients were divided randomly into 2 equal groups . In one group , <font color="blue">intramedullary_1</font> <font color="blue">alignment_1</font> <font color="blue">jigs_1</font> were used . In the second group , <font color="blue">custom_1</font> <font color="blue">-_1</font> <font color="blue">fit_1</font> <font color="blue">MRI_1</font> <font color="blue">-_1</font> <font color="blue">based_1</font> <font color="blue">pin_1</font> <font color="blue">guides_1</font> were used . All patients received the same cemented posterior - stabilized implant through a <font color="blue">mini_1</font> <font color="blue">-_1</font> <font color="blue">midvastus_1</font> <font color="blue">approach_1</font> <font color="blue">._1</font> The volume in the drain bottles was recorded after 48 h. <font color="blue">Hb_1</font> <font color="blue">loss_1</font> was estimated by subtracting the postoperative from the <font color="blue">preoperative_1</font> <font color="blue">Hb_1</font> <font color="blue">level_1</font> <font color="blue">._1</font> <font color="blue">Transfusion_1</font> <font color="blue">requirements_1</font> <font color="blue">and_1</font> <font color="blue">surgical_1</font> <font color="blue">time_1</font> <font color="blue">were_1</font> <font color="blue">recorded_1</font> <font color="blue">._1</font> Outcome measures were <font color="blue">Knee_2</font> <font color="blue">Society_2</font> <font color="blue">Scores_2</font> <font color="blue">(_2</font> <font color="blue">KSS_2</font> <font color="blue">)_2</font> <font color="blue">,_2</font> <font color="blue">knee_2</font> <font color="blue">flexion_2</font> <font color="blue">,_2</font> <font color="blue">knee_2</font> <font color="blue">swelling_2</font> <font color="blue">and_2</font> <font color="blue">pain_2</font> <font color="blue">._2</font> 
<br> RESULTS There was <font color="blue">lower_1</font> <font color="blue">mean_1</font> <font color="blue">drainage_2</font> <font color="blue">of_2</font> <font color="blue">blood_2</font> in the custom - fit group ( 391 ml vs. 603 ml ; p < 0.0001 ) . There was no difference in estimated <font color="blue">loss_1</font> <font color="blue">of_1</font> <font color="blue">Hb_1</font> ( 3.6 g / dl vs. 4.1 g / dl ; n.s . ) and in transfusion requirements ( 7.5 % vs. 10 % ; n.s . ) . Surgical time was reduced in the custom - fit group ( 12 min less ; p = 0.001 ) . <font color="blue">KSS_1</font> <font color="blue">measured_1</font> at week 2 , 6 and 12 showed no significant difference between groups . <font color="blue">Knee_1</font> <font color="blue">flexion_1</font> <font color="blue">measured_1</font> on days 7 , 10 and at week 6 , 12 and <font color="blue">knee_1</font> <font color="blue">swelling_1</font> <font color="blue">and_1</font> <font color="blue">pain_1</font> measured on days 1 , 3 , 10 and at week 6 , 12 showed no significant difference between groups . 
<br> CONCLUSIONS Using <font color="blue">custom_1</font> <font color="blue">-_1</font> <font color="blue">fit_1</font> <font color="blue">pin_1</font> <font color="blue">guides_1</font> <font color="blue">reduces_1</font> <font color="blue">blood_1</font> <font color="blue">drainage_1</font> <font color="blue">,_1</font> but not the estimated <font color="blue">Hb_1</font> <font color="blue">loss_1</font> in minimally invasive TKA and does <font color="blue">not_1</font> <font color="blue">affect_1</font> <font color="blue">transfusion_1</font> <font color="blue">rate_1</font> <font color="blue">._1</font> <font color="blue">Surgical_1</font> <font color="blue">time_1</font> <font color="blue">is_1</font> <font color="blue">reduced_1</font> <font color="blue">._1</font> There is <font color="blue">no_1</font> <font color="blue">effect_1</font> <font color="blue">on_1</font> <font color="blue">the_1</font> <font color="blue">early_1</font> <font color="blue">clinical_1</font> <font color="blue">outcomes_1</font> <font color="blue">._1</font> 
<br> LEVEL OF EVIDENCE Therapeutic study , Level I.